BKI Investment Company Limited reported a solid half-year performance for December 2024, maintaining stable revenue and lifting its fully franked dividend by 1%. The company also introduced a neutralised Dividend Reinvestment Plan to better align shareholder interests and capital structure.
Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.
